Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Response to concerns over primate brain studies
monkeys
Scientists raised concerns about the level of suffering involved in many neuroscience experiments.
Scientists say experiments are crucial for fighting human disease
 
Over 400 scientists have signed a letter claiming that research on primates is crucial for tackling neurodegenerative and other crippling diseases such as Parkinson's.

The letter, published by the Guardian, follows recent calls to end support for primate brain studies that involve fluid deprivation and movement restraint.

A group of 21 experts including Dr Jane Goodall and Sir David Attenborough last week wrote an open letter to UK and EU bodies that are responsible for licensing and funding brain experiments on monkeys.

They raised concerns about the level of suffering involved in many neuroscience experiments, particularly those depriving animals of water and restraining their movement, and said there are now sufficient human-based alternatives to 'call into serious question whether further research of this type is necessary.'

But hundreds of scientists have responded by saying research on non-human primates has played a key part in life-changing medical advances - including treatments for leprosy, HIV and Parkinson's - and their 'careful and considered use' is necessary for the ongoing fight against crippling human diseases.

'The biological similarities between humans and other primates mean that they are sometimes the only effective model for complex neurodegenerative diseases such as Parkinson's,' they wrote.

The group acknowledged that such research requires greater ethical justification due to the intelligence and sensitivity of non-human primates, and said the scientific community works together to minimise suffering 'wherever possible'.

They added: 'Stringent regulations across the developed world exist to ensure that primates are only used where there is no other available model – be that the use of a mouse or a non-animal alternative – and to protect the wellbeing of those animals still required. The use of primates is not undertaken lightly.'

However Dr Jane Goodall, who has studied chimpanzees for over 50 years, believes it is "morally wrong" to confine our primate relatives to laboratory cages and subject them to experiments that are often painful and distressing. In addition, she said fluid deprivation and movement restraint is "inhumane and extremely cruel".

 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.